Skip to main content

Table 1 Baseline characteristics (all-randomized set)

From: A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat

Characteristic

Miglustat + S. boulardii then miglustat + placebo

Miglustat + placebo then miglustat + S. boulardii

All subjects

(n = 21)

(n = 21)

(N = 42)

Age, mean (SD)

39.6 (8.9)

35.8 (10.8)

37.7 (10.0)

Gender, n (%) male

11 (52)

8 (38)

19 (45)

Race, n (%):

   

 Caucasian

12 (57)

8 (38)

20 (48)

 Black

4 (19)

11 (52)

15 (36)

 Asian

5 (24)

2 (10)

7 (17)

Mean weight, kg

72.7

71.7

72.2

BMI, mean (SD) kg/m2

25.5 (2.9)

25.4 (3.5)

25.4 (3.2)